Help Change The Future of Medicine

We are actively recruiting research participants in paid clinical trials. StarMed Healthcare has been involved in proving the safety and effectiveness of medications ranging from Diabetes care to Meningitis prevention to COVID-19 treatments. With our experienced research team, you can feel confident in the safety and success of the trials.

Our Active Studies.

Moderna KidCove Vaccine

Study Drug: Moderna COVID-19 Vaccine
An FDA approved for Emergency Use Authorization (EUA) vaccine for adults, Moderna is now testing the safety and efficacy for children under the age of 12.

This study does include the possibility of receiving a placebo.

NOT CURRENTLY ENROLLING

Study Design: “Kid Cove” is a study designed for vaccinating children under the age of 12 with lower dosing. The objective of this study is to determine the safety and effectiveness of their vaccine for children and prevent the spread of COVID-19 in those of young age.

Number of Visits: 7 Clinic visits, 2 Telemedicine visits, and a monthly phone visit.

You may be compensated for your time and travel.

*** When you send your email by clicking the button below, please be sure to include: Number of children with each child(s) age you would like to enroll, whether or not your child has had a previously confirmed COVID-19 diagnosis, child(s) ethnicity and the best phone number where we can reach you.

Pfizer C4671042 COVID-19 Treatment

Study Drug: NIRMATRELVIR/RITONAVIR

A Study to evaluate the efficacy and safety of a Repeat 5-Day treatment with Nirmatrelvir/Ritonavir in people with return of COVID-19 Symptoms and SARS-CoV-2 positivity after finishing treatment with Nirmatrelvir/Ritonavir

This study does include the possibility of receiving a placebo.

Study Design: Design: A patient must test positive and experience COVID-19 rebound symptoms within two weeks of completing a prescribed treatment of Paxlovid for a previous COVID-19 infection. If this criteria is met the patient will then begin the screening/randomization process of the study. Upon eligibility for the study the patient will receive a repeat 5-Day treatment of either Nirmatrelvir/Ritonavir or Placebo/Ritonavir. The objective of the study is to evaluate the efficacy and safety of a repeat dose of Nirmatrelvir/Ritonavir.

Number of Visits: 8 in patient visits, telemedicine visits, and 2 follow up visits via phone call over the course of 24 weeks.

ROCHE RD006575

Study Drug: J2X-MC-PYAH
Pilot COVID-19 & Flu A/B At-Home Test. Eli-Lilly is testing the clinical validation of the Pilot COVID-19 & Flu A/B At Home-Test in symptomatic patients.

Study Design: A patient must be over the age of 2 with COVID-19 and influenza within the last 7 days and has not received a SARS-CoV2 or influenza test result in the past 3 days. The patient would then begin the screening/randomization process. The object of the study is to evaluate the performance of the Pilot COVID-19 & Flu A/B At-Home Test compared to other EUA approved tests.

Number of Visits: 1 clinic visit